Global

Market Data

Global clinical trials activity decreases 8.8% YoY in Q4 2022

Carmen

//$tag = get_term_by('slug', 'featured', 'post_tag');

News

DTRA aims to connect the DCT community by launching a virtual meetup channel platform

//$tag = get_term_by('slug', 'featured', 'post_tag');

Features

Managed access programmes: expanding clinical development plans for patients in need

Features

Pipeline Moves: advancement prospects jump for Parkinson’s disease stem cell therapy

Comment

Shaping AML treatment: how menin inhibitors are changing the game

Comment

Childhood and young adult obesity increased risk of later thromboembolic events

News

Rett syndrome: How does Acadia’s trofinetide compare to ANAVEX2-73?

Features

Duchenne muscular dystrophy: major trials and events to watch in 2023

Comment

Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD

GlobalData Healthcare

Comment

30 years of failed trials put sepsis on track to be the main cause of death by 2050

GlobalData Healthcare

Comment

Merck’s MK-0616 may become the first oral PCSK9 inhibitor in the dyslipidemia market

GlobalData Healthcare

News

eConsent in clinical trials: what’s new and what’s yet to come?

Urtė Fultinavičiūtė

Features

Pipeline Moves: advancement prospects slump for lupus drug after negative topline data

Clinical Trials Arena Team

Comment

Positive data for PD-1 inhibitors in gastric cancer, but who can compete with Opdivo?

GlobalData Healthcare

Comment

R&D strategies in the lupus market

GlobalData Healthcare

Interviews

Q&A: Ethics of ultra-rare disease drug development and expanded access

William Newton

Features

Quantum medicine: how quantum computers could change drug development

William Newton

Comment

Novel Claudin 18.2-targeting therapy inching closer to approval in gastric cancer

GlobalData Healthcare

Features

Pipeline Moves: positive topline results for epilepsy drug, advancement prospects jump

Clinical Trials Arena Team

Partner Content

Meet the company on a mission to transform research and advance healthcare

alison

Partner Content

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

alison

Comment

Diabetic neuropathic pain market projected to grow at a CAGR of 6% between 2021-2031

GlobalData Healthcare

Features

Delaying type 1 diabetes progression: major trial readouts to watch in 2023

William Newton

News

Inflammatory bowel disease trials: addressing the challenge of declining enrolment

Urtė Fultinavičiūtė

Comment

Forever young: a new demographic?

GlobalData Thematic Research

Comment

First patients enrolled in Bayer’s Phase III trial for FXIa inhibitor asundexian

GlobalData Healthcare

News

What is BioGPT and what does it mean for healthcare?

William Newton

Features

Patient recruitment: can pharmacists fill both prescriptions and clinical trials?

Urtė Fultinavičiūtė

Features

Pipeline Moves: advancement prospects jump for cardiovascular gene therapy

Clinical Trials Arena Team

News

DCT Tracker update: decentralised clinical trials to reach new peak

Urtė Fultinavičiūtė

Features

mRNA vaccines: Four major clinical trial readouts to watch in 2023

William Newton

Comment

New RSV therapies may accelerate the emergence of resistant strains

GlobalData Healthcare

Comment

Cardiac arrest in the news headlines

GlobalData Healthcare

Features

Mapping endpoints: building gene therapy trials for the future

William Newton

Features

Predictive analytics in drug development: state of play

Urtė Fultinavičiūtė

Comment

Global malaria infections and deaths remained stable in 2021

GlobalData Healthcare

Features

Pipeline Moves: Trial completion bumps advancement prospects for AstraZeneca’s oncology drug

Clinical Trials Arena Team

Features

Five gene therapy trial readouts to watch in the first half of 2023

William Newton

Subscribe to our Newsletter